Tumour-reactive T cell subsets in the microenvironment of ovarian cancer
Research output: Contribution to journal › Journal article › Research › peer-review
Documents
- Tumour-reactive T cell subsets in the microenvironment of ovarian cancer
Final published version, 1.19 MB, PDF document
Background: Solid malignancies are frequently infiltrated with T cells. The success of adoptive cell transfer (ACT) with expanded tumour-infiltrating lymphocytes (TILs) in melanoma warrants its testing in other cancer types. In this preclinical study, we investigated whether clinical-grade TILs could be manufactured from ovarian cancer (OC) tumour specimens. Methods: Thirty-four tumour specimens were obtained from 33 individual patients with OC. TILs were analysed for phenotype, antigen specificity and functionality. Results: Minimally expanded TILs (Young TILs) were successfully established from all patients. Young TILs contained a high frequency of CD3 + cells with a variable CD4/CD8 ratio. TILs could be expanded to clinical numbers. Importantly, recognition of autologous tumour cells was demonstrated in TILs in >50% of the patients. We confirmed with mass spectrometry the presentation of multiple tumour antigens, including peptides derived from the cancer-testis antigen GAGE, which could be recognised by antigen-specific TILs. Antigen-specific TILs could be isolated and further expanded in vitro. Conclusion: These findings support the hypothesis that patients with OC can benefit from ACT with TILs and led to the initiation of a pilot clinical trial at our institution. Trial Registration: clinicaltrials.gov: NCT02482090.
Original language | English |
---|---|
Journal | British Journal of Cancer |
Volume | 120 |
Pages (from-to) | 424-434 |
ISSN | 0007-0920 |
DOIs | |
Publication status | Published - 2019 |
Number of downloads are based on statistics from Google Scholar and www.ku.dk
ID: 230247985